Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
vaccines
Biotech
Dynavax drops Tdap vaccine after mulling ph. 1 data, competition
Dynavax is giving up on its combination vaccine for tetanus, diphtheria and acellular pertussis after mulling phase 1 data for the shot.
James Waldron
Nov 8, 2024 9:31am
Medidata meshes services into oncology and vaccine trial bundles
Nov 5, 2024 3:40pm
Pfizer lets its RSV pipeline dry up in crowded space
Oct 29, 2024 11:23am
FDA puts Novavax's phase 3 plan on hold for pair of vaccines
Oct 16, 2024 9:10am
J&J drops phase 2 dengue candidate in latest shift from vaccines
Oct 4, 2024 10:14am
Vicebio hauls in $100M series B to push RSV shot through phase 1
Sep 23, 2024 3:00am
